Catalyst Wire Dossier Catalyst Wire Dossier

Bupropion hydrochloride sustained-release (generic)

Bupropion hydrochloride · Solco Healthcare US LLC
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Bupropion hydrochloride sustained-release (generic), covering 2024-02-15 to 2024-02-15. Get the full timeline:

Most recent: FDA Approved: BUPROPION HYDROCHLORIDE SR — Supplemental Application (Solco Healthcare US LLC)

See pricing